John Friend

Chief Executive Officer at KAZIA THERAPEUTICS LIMITED

Net worth: 150 $ as of 2026-05-30

56 year

Health Technology

Consumer Services

Profile

John E.
Friend is Chief Executive Officer & Director at Kazia Therapeutics Ltd. since 2024.
Formerly, Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018 and again from 2020 to 2021.
Chief Medical Officer at Druggability Technologies Holdings Ltd. (New Jersey).
Education includes undergraduate studies at Southern Methodist University and a doctorate from Robert Wood Johnson Medical School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
KAZIA THERAPEUTICS LTD 0.26%	2026-03-17	15,000,000 ( 0.26% )	150 $	2026-05-30

John Friend active positions

Companies	Position	Start
KAZIA THERAPEUTICS LIMITED	Chief Executive Officer	2023-04-30

All active positions of John Friend

Former positions of John Friend

Companies	Position	End
CELLECTAR BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	2021-11-01
CELLECTAR BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	2018-11-26
Helsinn Therapeutics (U.S.), Inc. Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer	Chief Tech/Sci/R&D Officer	2017-03-31
Druggability Technologies Holdings Ltd. (New Jersey)	Chief Tech/Sci/R&D Officer	-

See the detail of John Friend's experience

Training of John Friend

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Friend's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Kazia Therapeutics Ltd. Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development	Health Technology
Southern Methodist University Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Robert Wood Johnson Medical School Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Helsinn Therapeutics (U.S.), Inc. Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer	Health Technology
Cellectar Biosciences, Inc. Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer	Health Technology
Druggability Technologies Holdings Ltd. (New Jersey)